Kwazi B. Gabuza

Cape Town, WC 7505, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Doxorubicin-Induced Cardiomyopathy: A Preliminary Study on the Cardioprotective Benefits of 7-Hydroxyflavanone.

Doxorubicin-Induced Cardiomyopathy: A Preliminary Study on the Cardioprotective Benefits of 7-Hydroxyflavanone.

Journal: International journal of molecular sciences

Published: September 14, 2023

Cyclopia intermedia (Honeybush) Induces Uncoupling Protein 1 and Peroxisome Proliferator-Activated Receptor Alpha Expression in Obese Diabetic Female db/db Mice.

Cyclopia intermedia (Honeybush) Induces Uncoupling Protein 1 and Peroxisome Proliferator-Activated Receptor Alpha Expression in Obese Diabetic Female db/db Mice.

Journal: International journal of molecular sciences

Published: December 15, 2022

Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies.

Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies.

Journal: Frontiers in cardiovascular medicine

Published: March 29, 2022

Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice.

Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice.

Journal: International journal of environmental research and public health

Published: February 24, 2022

Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation.

Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation.

Journal: Archives of toxicology

Published: January 12, 2022

Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of NAFLD.

Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of NAFLD.

Journal: PloS one

Published: August 06, 2021

Metformin and heart failure-related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials.

Metformin and heart failure-related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials.

Journal: Heart failure reviews

Published: March 12, 2020

Exploring the Comparative Efficacy of Metformin and Resveratrol in the Management of Diabetes-associated Complications: A Systematic Review of Preclinical Studies.

Exploring the Comparative Efficacy of Metformin and Resveratrol in the Management of Diabetes-associated Complications: A Systematic Review of Preclinical Studies.

Journal: Nutrients

Published: February 13, 2020

Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels.

Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels.

Journal: Heart and vessels

Published: February 06, 2017

Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression.

Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression.

Journal: Molecules (Basel, Switzerland)

Published: November 14, 2016

Phenylpyruvic Acid-2-O-β-D-Glucoside Attenuates High Glucose-Induced Apoptosis in H9c2 Cardiomyocytes.

Phenylpyruvic Acid-2-O-β-D-Glucoside Attenuates High Glucose-Induced Apoptosis in H9c2 Cardiomyocytes.

Journal: Planta medica

Published: July 13, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026